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Background: Emerging epidemiological evidence suggest an association between metabolic syndrome and
fractures. However, whether metabolic syndrome is an independent risk or protective factor of fractures remains
controversial. Our goal is to provide a quantitative assessment of the association between metabolic syndrome and
bone fractures by conducting a meta-analysis of observational studies.
Methods: The PubMed and Embase database were searched through to March 2013 to identify studies that met
pre-established inclusion criteria. Reference lists of retrieved articles were also reviewed. Summary effect estimates with
95% confidence intervals (CI) were derived using a fixed or random effects model, depending on the heterogeneity of
the included studies.
Results: Eight epidemiologic studies involving 39,938 participants were included in the meta-analysis. In overall analysis,
metabolic syndrome was not associated with prevalent fractures [pooled odds ratio (OR) 0.93, 95% CI 0.84 - 1.03]
in cross-sectional studies or incident fractures [pooled relative risk (RR) 0.88, 95% CI 0.37 - 2.12] in prospective
cohort studies. No evidence of heterogeneity was found in cross-sectional studies (p = 0.786, I2 = 0.0%). A
substantial heterogeneity was detected in cohort studies (p = 0.001, I2 = 85.7%). No indication of significant
publication bias was found either from Begg’s test or Egger’s test. Estimates of total effects were substantially
consistent in the sensitivity and stratification analyses.
Conclusions: The present meta-analysis of observational studies suggests that the metabolic syndrome has no
explicit effect on bone fractures.
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Metabolic syndrome includes the constellation of various
metabolic abnormalities and confers an increased risk for
diabetes and cardiovascular diseases. It is becoming a glo-
bal burden because the prevalence of metabolic syndrome
in adult was around 20-25% all over the world [1]. Osteo-
porotic fractures among the older people are also a major* Correspondence: gning@sibs.ac.cn
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stated.health problem leading to increased mortality and mor-
bidity and significant costs on public-health budgets [2,3].
The association between metabolic syndrome and
osteoporotic fractures has been analyzed in recent epi-
demiological studies, but the results are quite discordant.
Muhlen D et al. [4] found that incidence of osteoporotic
non-vertebral fractures was higher in participants with
metabolic syndrome in the Rancho Bernardo Study.
However, as reported in the Third National Health and
Nutrition Examination Survey (NHANES III), no differ-
ence in prevalence of non-vertebral fractures was found
between people with and without metabolic syndrome
[5]. Similarly on non-vertebral fractures, Luai A. Ahmed
et al. [6] found that metabolic syndrome have a signifi-
cant protective effect on its risk in the Tromsø Study.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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metabolic syndrome have lower bone mineral density
(BMD) but lower fracture risk in the MINOS study.
Nevertheless, a later meta-analysis suggests that meta-
bolic syndrome has no clear influence on BMD, or its in-
fluence maybe beneficial [8].
Combined with early epidemiological studies, the real
pattern of metabolic syndrome on fractures has not
been clearly elucidated. Moreover, previously existing
primary analyses on this association did not complete a
meta-analysis of data sources. Therefore, the present
meta-analysis of the literature aims to obtain an over-




We conducted a systematic review of the published works
without language restrictions and in accordance with the
Meta-analysis of Observational Studies in Epidemiology
(MOOSE) guidelines [9]. We searched Pubmed and
Embase from their inception to March 2013 and systemat-
ically identified observational studies that evaluated the
association between metabolic syndrome and incidence or
prevalence of fractures. We used the following main
search terms with no restrictions: “metabolic syndrome”
or “insulin resistance syndrome” or “syndrome X” in com-
bination with “bone” or “fracture” or “osteoporosis” or
“metabolic bone diseases ” or “osteopenia” or “bone min-
eral density” or “BMD”. We also scanned the reference
lists from published original articles and previous reviews
for more relevant studies not identified in the databases
search.
Study selection
We included studies in the meta-analysis that met all of
the following criteria: (1) the study had a population
based observational design, (2) published original data
relevant to a possible association between metabolic syn-
drome and fractures, (3) reported the odds ratio (OR) or
relative risk (RR) and its 95% confidence interval (CI). In
case of multiple publications had overlap their popula-
tions and reported with the same study design, the most
recent publication was included in order to avoid dupli-
cate observation, unless more inclusive and detailed data
was found in other publications. To gather more relevant
information, we consulted researchers with professional
knowledge at this area for the presence of unpublished
reports.
Data extraction
Two of our reviewers independently evaluated all relevant
articles and identified eligible studies from the databases.
During data abstraction, differences and disagreementswere resolved through discussion to come to an agree-
ment. Following information was recorded by a standard-
ized data extraction form: last name of the first author,
publication year, name of the study, geographic region of
original study, composition and age range of study popula-
tion, type of fractures, definitions of metabolic syndrome,
unadjusted and adjusted OR or RR with corresponding
95% CI and adjustment factors of interest. If possible, we
also extracted the baseline data of cohort studies for the
combined estimates. We contacted authors of the primary
studies for additional information when necessary.Statistical analysis
The primary outcome of the pooled analysis was focused
on a comparison of the summary effect of fractures risk
in people with metabolic syndrome versus those without.
Both unadjusted and adjusted values were extracted for
the pooled analysis. When studies presented results from
various covariates analyses, we used the one adjusted the
most study-specific confounders. The combined esti-
mates were calculated separately by averaging the nat-
ural logarithmic OR or RR weighted by their inverse of
variance based on a fixed or random effects model
within or between study variations, depending on the
overall heterogeneity. Heterogeneity of effect size across
studies was assessed by using Cochran’s Q and the I2
statistic [10,11] and p value < 0.10 or I2 value > 50% was
considered to be heterogeneous. In the I2 statistic, values
of 25, 50, and 75% are considered to represent low,
medium, and high heterogeneity, respectively. If substan-
tial heterogeneity was detected, pooled effect estimates
were calculated using a random effects model by the
method of DerSimonian and Laird [12]. If not, the com-
bined estimates were presented based on the fixed ef-
fects model by using the inverse variance method [13].
To assess the influence of individual studies on the
pooled result, we conducted sensitivity analyses to inves-
tigate the influence of a single study on the overall risk
estimate by omitting one study in each turn. We used
the Begg’ s adjusted rank correlation test and the Egger’ s
regression asymmetry test to detect publication bias and
p > 0.05 for both tests was considered to be no significant
publication bias [14,15]. Subgroup analyses according
to sex (male/female), types of fractures (non-vertebral/
vertebral/any fractures), definitions of metabolic syn-
drome [strict National Cholesterol Education Program’ s
Adult Treatment Panel III (NCEP-ATP III) criteria-
2001/strict NCEP-ATP III criteria-2005/other modified
criteria] and geographical area (Europe/America/Asia)
were used to assess the impacts of study characteristics
on outcomes.
All statistical analyses were performed using STATA
version 11.0 (Stata Corp, College Station, TX, USA).
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The details of the literature search were presented in
a flow diagram (Figure 1). We identified 1,410 citations
(561 from Pubmed and 849 from Embase) with the elec-
tronic literature search. We first excluded 246 citations
for the duplicate data in the databases. Then we ex-
cluded 1,149 citations by screening abstracts or titles.
After this, fifteen remaining citations were identified for
further full-text reviewed. Finally, eight citations met the
inclusion criteria were included in the data analysis.
The characteristics and information of the included
studies were showed in Table 1. Totally, the 8 selected
studies contained 39,938 participants. Among the 8 in-
cluded studies, five studies showed no significant correl-
ation between metabolic syndrome and prevalent
fractures [5,16-19]. However, in the Rancho Bernardo
Study, incidence of osteoporotic fractures was significant
higher in patients with metabolic syndrome compared to
those without [4]. By contrast, in the Tromsø prospect-
ive study, a significant protective effect of metabolic syn-
drome against non-vertebral fractures was found in both
sexes [6]. Metabolic syndrome was associated with a
lower fracture incidence in the MINOS study [7].
In overall analysis of the 8 selected studies, metabolic
syndrome was not associated with prevalent fractures in
cross-sectional studies (Figure 2, pooled OR 0.93, 95%
CI 0.84 - 1.03) or incident fractures in prospective co-
hort studies (Figure 3, pooled RR 0.88, 95% CI 0.37 -
2.12). Statistically significant evidence of heterogeneity
was found in cohort studies (p = 0.001, I2 = 85.7%) but not
in cross-sectional studies (p = 0.786, I2 = 0.0%). There was
no indication of significant publication bias either fromFigure 1 Flow diagram of included studies in the systematic review.the result of Begg’s test (p = 0.133 for cross-sectional stud-
ies and p = 1.000 for prospective cohort studies) or from
the Egger’s test (p = 0.054 for cross-sectional studies and
p = 0.893 for prospective cohort studies).
Sensitivity analyses of our primary outcome were carried
out by excluding one study at a time and the combined
overall risk estimates were consistent, with a range from
0.91 (95% CI 0.80 - 1.03) to 0.94 (95% CI 0.84 - 1.05) in
cross-sectional studies and 0.56 (95% CI 0.24 - 1.29) to
1.35 (95% CI 0.42 - 4.32) in prospective cohort studies, re-
spectively. As only 3 prospective cohort studies were in-
cluded in the meta-analysis, we conducted the subgroup
analyses by only adopting the cross-sectional data. As
shown in Table 2, the results of subgroup analyses accord-
ing to different characteristics are in close agreement with
our major finding.
Discussion
According to the observational data in the past decade,
the relationship between metabolic syndrome and osteo-
porotic fractures is controversial. Findings of the present
meta-analysis show no clear link between metabolic syn-
drome and fractures. The combined estimate of our pri-
mary analysis is strong across sensitivity analyses and
without significant publication bias. Despite the limited
numbers of studies in this area, we found that cross-
sectional studies yield estimates of the pooled effect of
metabolic syndrome on bone fractures were in agree-
ment with those from prospective cohort studies.
The influence of metabolic syndrome on bone frac-
tures is complicated. When explored such association,
we should notice that the two diseases states share
Table 1 Characteristics of included studies
Source Region Study name Study type& Paticipants (new cases) Age range (years) Metabolic syndrome measures Type of fractures
Ahmed [6] Norway The Tromsø Study Prospective All: 26,905* 25 - 98 NCEP-ATP III Non-vertebral fractures
(6 years) (1,227)
Mitsuyo [5] USA NHANES III Cross-sectional Male: 4,026 20 or older NCEP-ATP III Non-vertebral fractures
Female: 4,171
von Muhlen [4] USA The Rancho Bernardo Study Prospective (2 years) Male: 420 (9) Male: 74.2 ± 9.7 NCEP-ATP III Non-vertebral fractures
Female: 676 (22) Female: 74.4 ± 10.9
Yamaguchi [16] Japan N.A.# Cross-sectional Male: 187 Male: 59.7 ± 13.5 Japanese criteria Vertebral fractures
Female: 125 Female: 64.7 ± 10.9
Hernández [17] Spain The Camargo Cohort Study Cross-sectional Male: 495 Male: 65.0 ± 9.0 NCEP-ATP III Any fractures
Female: 1,013 Female: 63.0 ± 9.0
Kim [18] South Korea N.A. Cross-sectional Female: 907 60 - 79 NCEP-ATP III Vertebral fractures
Szulc [7] France The MINOS Study Prospective (10 years) Male: 762 (82) 50 - 85 NCEP-ATP III Any fractures
Ferre [19] Spain The PREDIMED Study Cross-sectional Male: 124 Male: 55–80 NCEP-ATP III Any fractures
Female: 127 Female: 60 - 80
&Follow-up duration (years) if a prospective design.
*Relevant data from erratum on Osteoporos Int [6] 20:839.



















Figure 2 Forest plot showing combined estimates of metabolic syndrome and prevalence of fractures.
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cigarette smoking and alcohol drinking [20-23]. The oc-
currence of fractures may be directly mediated by expos-
ure of these risk factors, not by metabolic syndrome itself.
Moreover, the diagnosis of metabolic syndrome is the in-
clusion of various combinations as a whole, which result
in subjects with the disease becoming a considerably het-
erogeneous group. Therefore, when addressing the rela-
tionship between metabolic syndrome and fractures, itFigure 3 Forest plot showing combined estimates of metabolic syndrshould be more appropriate to evaluate the effects of indi-
vidual components of metabolic syndrome on bone
fractures.
Previous studies have shown that elevated blood pres-
sure is a risk factor for fractures [24]. However, as another
component of the metabolic syndrome, hypertriglyc-
eridemia contribute to a lower risk of low-trauma frac-
tures, which may partly because triglycerides mediate the
interaction between the protein matrix and bone mineralsome and incidence of fractures.
Table 2 Stratified risk estimates of the association between metabolic syndrome and bone fractures
Group NO. of studies OR (95% CI) p for heterogeneity I
2 (%)
Sex
Male 3 0.89 (0.72 - 1.11) 0.254 27
Female 3 0.94 (0.81 - 1.10) 0.614 0.0
Type of fractures
Non-vertebral fractures 1 0.98 (0.80 - 1.20) – –
Vertebral fractures 2 0.86 (0.61 - 1.20) 0.687 0.0
Any fractures* 3 0.92 (0.80 - 1.05) 0.415 0.0
Definitions of metabolic syndrome
NCEP-ATP III criteria-2001 3 0.96 (0.80 - 1.13) 0.844 0.0
NCEP-ATP III criteria-2005 2 0.93 (0.81 - 1.07) 0.203 38.4
Other criteria 1 0.80 (0.50 - 1.29) – –
Geographical area
Europe 3 0.92 (0.80 - 1.05) 0.415 0.0
America 1 0.98 (0.80 - 1.20) – –
Asia 2 0.86 (0.61 - 1.20) 0.687 0.0
*Specific classification of fractures was not available in these studies.
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protein may protect against fractures in women and obese
men [6]. Some of other metabolic syndrome components
may just play a discordant role in the relationship between
metabolic syndrome and fractures. Metabolic syndrome is
a risk factor for diabetes which might expect an increase
in fracture risk. Actually, patients with type 2 diabetes had
an increased fracture risk in spite of a higher BMD level,
which may partly cause by the increased risk of falling
[26]. Strotmeyer et al. [27] found that subjects with type 2
diabetes mellitus may suffer from higher risk of osteopor-
otic fractures. However, impaired fasting plasma glucose is
not associated with fracture risk in the same study.
Gagnon C et al. [28] reported that incident fractures
were reduced in individuals with elevated 2 hours
plasma glucose levels and pre-diabetes independently of
BMI and fasting insulin levels. Therefore, increased
awareness of the association between metabolic syn-
drome and fractures is still needed in view of the above
argument and growing population of patients with dia-
betes and impaired glucose regulation [29]. In addition,
obesity is a risk factor for fractures of the humerus and
ankle but protects against fractures of hip and vertebral
[30-32]. Additionally, the association between obesity
and fractures appears to vary with age. Dimitri et al.
[33] found that obesity is a risk factor of fractures in
children but a protective factor of fractures in adults.
Future studies are needed to search for more credible
evidence and identify the exact mechanisms that link
obesity to fracture risk [34]. Base on the above argu-
ments, we assume that the concept of metabolic syn-
drome may be slightly far-fetched in the context offractures. The controversial results of the included
studies in this meta-analysis may mainly depend on the
discrepancy between each individual component of
metabolic syndrome and bone fractures. Moreover, the
negative findings of current meta-analysis, to some ex-
tent, just verify this viewpoint.
There were several limitations to this meta-analysis.
First, the distinct definition of metabolic syndrome
might provide biased estimates on bone fractures. More-
over, the Tromsø Study took non-fasting samples for
testing glucose and triglycerides levels and used BMI in-
stead of waist circumference to define metabolic syn-
drome. Actually, a variety of definitions of metabolic
syndrome has existed for at least ten decades. Among
these definitions, the NCEP-ATP III definition is widely
used in both clinical and epidemiological studies. In the
current analysis, nevertheless, metabolic syndrome was
defined by rigorous NCEP-ATP III criteria in most of
the included studies and pooled results of prevalent frac-
tures were kept consistent in subgroup analyses. Second,
the present analysis may be subject to recall bias of frac-
tures because most studies included participants 50 years
or older. However, fracture is one of the major health
events in life and rarely to be forgotten or misremem-
bered. Second, the availability of articles in this area was
relatively limited. To better elucidate the association be-
tween metabolic syndrome and fractures, we included
both cross-sectional and prospective cohort studies in the
present meta-analysis. The inclusion of cross-sectional
studies may result in high potential for intractable con-
founding and reverse causation. However, the pooled re-
sults from cross-sectional studies were in close agreement
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dence of heterogeneity was found in cross-sectional stud-
ies. Third, although most of the included studies made
attempt to control for the confounding variables, not all
of the residual and potential mediators were adjusted and
took into account, which could contribute to a superfi-
cially conclusion of our findings. Finally, a substantial de-
gree of heterogeneity, partly due to diversity in fractures
types and the duration of follow up, was detected among
cohort studies. For example, fractures in the Tromsø
Study were not limited to non-trauma fractures. More-
over, the Rancho Bernardo Study found an increased risk
of fractures in people with metabolic syndrome had only
2 years of follow-up. In the Tromsø Study and the MINOS
Study, had a longer follow-up of 6 and 10 years, respect-
ively, found a reduced risk of fractures in people with
metabolic syndrome. However, such heterogeneity was
not surprising because of unavoidable variations in study
population and distinct adjustments across studies. More-
over, overall risk estimates of cohort studies did not sub-
stantially modified through the sensitivity analyses.
Conclusion
In conclusion, the present meta-analysis collected and
synthesized data currently available and found that
metabolic syndrome is not clearly associated with preva-
lence or incidence of fractures. In consideration of the
high heterogeneity of the prospective studies and limita-
tions of the data consolidation, further longitudinal stud-
ies are urgently needed to make definite conclusion on
this issue.
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